These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8832646)

  • 1. Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease.
    Lefranc D; Vermersch P; Dallongeville J; Daems-Monpeurt C; Petit H; Delacourte A
    Neurosci Lett; 1996 Jul; 212(2):91-4. PubMed ID: 8832646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions.
    Skoog I; Hesse C; Fredman P; Andreasson LA; Palmertz B; Blennow K
    Arch Neurol; 1997 Mar; 54(3):267-72. PubMed ID: 9074395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid apo E and apo A-I concentrations in early- and late-onset Alzheimer's disease.
    Song H; Saito K; Seishima M; Noma A; Urakami K; Nakashima K
    Neurosci Lett; 1997 Aug; 231(3):175-8. PubMed ID: 9300650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau and apo E in CSF: potential aid for discriminating Alzheimer's disease from other dementias.
    Molina L; Touchon J; Herpé M; Lefranc D; Duplan L; Cristol JP; Sabatier R; Vermersch P; Pau B; Mourton-Gilles C
    Neuroreport; 1999 Nov; 10(17):3491-5. PubMed ID: 10619631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.
    Zimetti F; Caffarra P; Ronda N; Favari E; Adorni MP; Zanotti I; Bernini F; Barocco F; Spallazzi M; Galimberti D; Ricci C; Ruscica M; Corsini A; Ferri N
    J Alzheimers Dis; 2017; 55(1):315-320. PubMed ID: 27662294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of apolipoprotein E (apoE) in cerebrospinal fluid.
    Hesse C; Larsson H; Fredman P; Minthon L; Andreasen N; Davidsson P; Blennow K
    Neurochem Res; 2000 Apr; 25(4):511-7. PubMed ID: 10823584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent decline in the apolipoprotein E level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer's disease.
    Fukuyama R; Mizuno T; Mori S; Yanagisawa K; Nakajima K; Fushiki S
    Eur Neurol; 2000; 43(3):161-9. PubMed ID: 10765057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease.
    Merched A; Blain H; Visvikis S; Herbeth B; Jeandel C; Siest G
    J Neurol Sci; 1997 Jan; 145(1):33-9. PubMed ID: 9073026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry.
    Merched A; Serot JM; Visvikis S; Aguillon D; Faure G; Siest G
    FEBS Lett; 1998 Mar; 425(2):225-8. PubMed ID: 9559653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.
    Blennow K; Hesse C; Fredman P
    Neuroreport; 1994 Dec; 5(18):2534-6. PubMed ID: 7696597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sandwich ELISA for the measurement of Apo-E4 levels in serum and the estimation of the allelic status of Apo-E4 isoforms.
    Uchida Y; Ito S; Nukina N
    J Clin Lab Anal; 2000; 14(6):260-4. PubMed ID: 11138606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra vitam lumbar cerebrospinal fluid and serum and postmortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer's disease.
    Rösler N; Wichart I; Jellinger KA
    J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):452-4. PubMed ID: 8774418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid lipoproteins in Alzheimer's disease.
    Bassett CN; Montine KS; Neely MD; Swift LL; Montine TJ
    Microsc Res Tech; 2000 Aug; 50(4):282-6. PubMed ID: 10936881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease.
    Ueki A; Kawano M; Namba Y; Kawakami M; Ikeda K
    Neurosci Lett; 1993 Dec; 163(2):166-8. PubMed ID: 8309625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal beta-amyloid ((1-42)) in early Alzheimer's disease: association with apolipoprotein E genotype and cognitive decline.
    Riemenschneider M; Schmolke M; Lautenschlager N; Guder WG; Vanderstichele H; Vanmechelen E; Kurz A
    Neurosci Lett; 2000 Apr; 284(1-2):85-8. PubMed ID: 10771168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of cerebrospinal fluid apolipoprotein E in patients with Alzheimer's disease and healthy controls.
    Hahne S; Nordstedt C; Ahlin A; Nybäck H
    Neurosci Lett; 1997 Mar; 224(2):99-102. PubMed ID: 9086466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid apolipoprotein E concentration and progression of Alzheimer's disease.
    Schmidt C; Gerlach N; Peter C; Gherib K; Lange K; Friede T; Zerr I
    J Alzheimers Dis; 2015; 43(4):1229-36. PubMed ID: 25125466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.